Two-year experience with FK 506 in pediatric patients.
作者信息
Tzakis A G, Reyes J, Todo S, Nour B, Shapiro R, Jordan M, McCauley J, Armitage J, Fung J J, Starzl T E
机构信息
Transplant Institute, University of Pittsburgh, PA 15213.
出版信息
Transplant Proc. 1993 Feb;25(1 Pt 1):619-21.
Abstract
摘要
相似文献
1
Two-year experience with FK 506 in pediatric patients.FK506在儿科患者中的两年应用经验。
Transplant Proc. 1993 Feb;25(1 Pt 1):619-21.
2
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Transplant Proc. 1998 Jun;30(4):1116-7. doi: 10.1016/s0041-1345(98)00174-2.
3
Therapy with FK 506 in pediatric liver recipients.
Transplant Proc. 1994 Feb;26(1):152-3.
4
Tacrolimus in solid organ transplantation: an update.实体器官移植中的他克莫司：最新进展
Transplant Proc. 1999 Sep;31(6):2203-5. doi: 10.1016/s0041-1345(99)00306-1.
5
Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.小儿心脏移植受者的免疫抑制转换：从环孢素转换为FK506。
J Am Coll Cardiol. 1995 Apr;25(5):1183-8. doi: 10.1016/0735-1097(94)00551-z.
6
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
Transplant Proc. 1996 Apr;28(2):1002-4.
7
FK 506 dose in transplantation: from theory to practice.移植中FK 506的剂量：从理论到实践
Transplant Proc. 2001 Jun;33(4):2594-7. doi: 10.1016/s0041-1345(01)02107-8.
8
Controversies in heart and lung transplantation immunosuppression: tacrolimus versus cyclosporine.
Transplant Proc. 1998 Jun;30(4):1095-7. doi: 10.1016/s0041-1345(98)00167-5.
9
Combined orthotopic liver-small bowel transplantation or small bowel transplantation in pigs: relations between survival, rejection, and mucosal morphometry.
Transplant Proc. 1997 May;29(3):1840-1. doi: 10.1016/s0041-1345(97)00091-2.
10
Graft-versus-host reaction and graft rejection after liver, small bowel or small bowel allotransplantation in the pig.
Transplant Proc. 1998 Sep;30(6):2601-4. doi: 10.1016/s0041-1345(98)00746-5.
引用本文的文献
1
Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation.他克莫司或环孢素A微乳剂在儿童肝移植术后的随机试验长期随访
Transplant Direct. 2021 Sep 20;7(10):e765. doi: 10.1097/TXD.0000000000001221. eCollection 2021 Oct.
2
Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.他克莫司在实体器官移植中的临床药代动力学与药效学
Clin Pharmacokinet. 2004;43(10):623-53. doi: 10.2165/00003088-200443100-00001.
3
Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.小儿肝移植受者从环孢素转换为他克莫司。
Paediatr Drugs. 2001;3(9):661-72. doi: 10.2165/00128072-200103090-00004.
4
Immunosuppressive drugs in paediatric liver transplantation.儿童肝移植中的免疫抑制药物
Paediatr Drugs. 2001;3(1):43-60. doi: 10.2165/00128072-200103010-00004.
5
Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients.他克莫司在亚洲儿童肝移植患者中的群体药代动力学。
Br J Clin Pharmacol. 2000 Dec;50(6):531-41. doi: 10.1046/j.1365-2125.2000.00288.x.
6
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.他克莫司与环孢素在儿童肝移植中的长期比较评估。
Transplantation. 2000 Aug 27;70(4):617-25. doi: 10.1097/00007890-200008270-00015.
7
Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.他克莫司（FK506）在儿童肝移植受者中的药代动力学。
Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep;23(3):367-70. doi: 10.1007/BF03192295.
8
Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients.糖尿病作为小儿肾移植患者使用他克莫司（FK506）的并发症。
Pediatr Nephrol. 1996 Feb;10(1):64-6. doi: 10.1007/BF00863448.
9
Clinical use of tacrolimus (FK-506) in infants and children with renal transplants.
Pediatr Nephrol. 1995 Aug;9(4):487-94. doi: 10.1007/BF00866738.
10
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.上腹部脏器切除及肝脏置换术后的胰岛移植
Lancet. 1990 Aug 18;336(8712):402-5. doi: 10.1016/0140-6736(90)91946-8.
2
FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome.FK506在移植相关性肾病综合征和激素抵抗性肾病综合征治疗中的应用
Transplant Proc. 1991 Dec;23(6):3354-6.
3
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.骨髓移植后慢性移植物抗宿主病中FK 506的挽救治疗
Transplant Proc. 1991 Dec;23(6):3225-7.
4
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.儿童移植人群中与FK 506相关的糖尿病是一种罕见的并发症。
Transplant Proc. 1991 Dec;23(6):3171-2.
5
FK 506 conversion of renal allografts failing cyclosporine immunosuppression.对因环孢素免疫抑制失败的肾移植受者进行FK506转换治疗。
Transplant Proc. 1991 Dec;23(6):3078-81.
6
Pediatric renal transplantation under FK 506 immunosuppression.在FK 506免疫抑制下的小儿肾移植
Transplant Proc. 1991 Dec;23(6):3075-7.
7
The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation.FK 506作为小儿心脏移植主要和挽救性免疫抑制治疗的临床试验。
Transplant Proc. 1991 Dec;23(6):3058-60.
8
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.在原发性FK 506免疫抑制下发生的移植后淋巴细胞增生性疾病。
Transplant Proc. 1991 Dec;23(6):3044-6.
9
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
10
Use of FK 506 in pediatric patients.FK506在儿科患者中的应用。
Transplant Proc. 1991 Feb;23(1 Pt 2):924-7.
Zotero 插件